These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20415637)

  • 1. The relationship between antibody to R7V and progression of HIV type 1 infection.
    Margolick JB; Da Costa Castro JM; Sanchez A; Gemrot F; Phair JP; Jamieson BD; Rinaldo CR; Jacobson LP
    AIDS Res Hum Retroviruses; 2010 Apr; 26(4):389-94. PubMed ID: 20415637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigation of anti-R7V antibodies in HIV-infected patients under highly active antiretroviral therapy].
    Ergünay K; Altinbaş A; Calik Başaran N; Unal S; Us D; Karabulut E; Ustaçelebi S
    Mikrobiyol Bul; 2008 Jul; 42(3):413-9. PubMed ID: 18822884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-B alleles associate consistently with HIV heterosexual transmission, viral load, and progression to AIDS, but not susceptibility to infection.
    Gao X; O'Brien TR; Welzel TM; Marti D; Qi Y; Goedert JJ; Phair J; Pfeiffer R; Carrington M
    AIDS; 2010 Jul; 24(12):1835-40. PubMed ID: 20588164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of HLA profiles with early plasma viral load, CD4+ cell count and rate of progression to AIDS following acute HIV-1 infection. Multicenter AIDS Cohort Study.
    Saah AJ; Hoover DR; Weng S; Carrington M; Mellors J; Rinaldo CR; Mann D; Apple R; Phair JP; Detels R; O'Brien S; Enger C; Johnson P; Kaslow RA
    AIDS; 1998 Nov; 12(16):2107-13. PubMed ID: 9833851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.
    Hogg RS; Yip B; Chan KJ; Wood E; Craib KJ; O'Shaughnessy MV; Montaner JS
    JAMA; 2001 Nov; 286(20):2568-77. PubMed ID: 11722271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
    Sterling TR; Vlahov D; Astemborski J; Hoover DR; Margolick JB; Quinn TC
    N Engl J Med; 2001 Mar; 344(10):720-5. PubMed ID: 11236775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid disease progression in human immunodeficiency virus type 1-infected seroconverters in India.
    Mehendale SM; Bollinger RC; Kulkarni SS; Stallings RY; Brookmeyer RS; Kulkarni SV; Divekar AD; Gangakhedkar RR; Joshi SN; Risbud AR; Thakar MA; Mahajan BA; Kale VA; Ghate MV; Gadkari DA; Quinn TC; Paranjape RS
    AIDS Res Hum Retroviruses; 2002 Nov; 18(16):1175-9. PubMed ID: 12487823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early viral load and CD4+ T cell count, but not percentage of CCR5+ or CXCR4+ CD4+ T cells, are associated with R5-to-X4 HIV type 1 virus evolution.
    van Rij RP; Hazenberg MD; van Benthem BH; Otto SA; Prins M; Miedema F; Schuitemaker H
    AIDS Res Hum Retroviruses; 2003 May; 19(5):389-98. PubMed ID: 12803997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
    HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART).
    Dold L; Ahlenstiel G; Althausen E; Luda C; Schwarze-Zander C; Boesecke C; Wasmuth JC; Rockstroh JK; Spengler U
    PLoS One; 2015; 10(8):e0134158. PubMed ID: 26241854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disentangling human tolerance and resistance against HIV.
    Regoes RR; McLaren PJ; Battegay M; Bernasconi E; Calmy A; Günthard HF; Hoffmann M; Rauch A; Telenti A; Fellay J;
    PLoS Biol; 2014 Sep; 12(9):e1001951. PubMed ID: 25226169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum HIV-1 RNA levels compared to soluble markers of immune activation to predict disease progression in HIV-1-infected individuals.
    Zangerle R; Steinhuber S; Sarcletti M; Dierich MP; Wachter H; Fuchs D; Möst J
    Int Arch Allergy Immunol; 1998 Jul; 116(3):228-39. PubMed ID: 9693271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.
    O'Brien WA; Hartigan PM; Martin D; Esinhart J; Hill A; Benoit S; Rubin M; Simberkoff MS; Hamilton JD
    N Engl J Med; 1996 Feb; 334(7):426-31. PubMed ID: 8552144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body mass index course in asymptomatic HIV-infected homosexual men and the predictive value of a decrease of body mass index for progression to AIDS.
    Maas JJ; Dukers N; Krol A; van Ameijden EJ; van Leeuwen R; Roos MT; de Wolf F; Coutinho RA; Keet IP
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):254-9. PubMed ID: 9803967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral load and CD4 count dynamics after HIV-1 seroconversion in homosexual and bisexual men in Rio de Janeiro, Brazil.
    Djomand G; Duerr A; Faulhaber JC; Struchiner CJ; Pacheco AG; Barroso PF; Melo MF; Schechter M
    J Acquir Immune Defic Syndr; 2006 Dec; 43(4):401-4. PubMed ID: 17031316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient.
    Brener J; Gall A; Hurst J; Batorsky R; Lavandier N; Chen F; Edwards A; Bolton C; Dsouza R; Allen T; Pybus OG; Kellam P; Matthews PC; Goulder PJR
    Retrovirology; 2018 Jan; 15(1):7. PubMed ID: 29338738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between different anti-Tat antibody isotypes and HIV disease progression: data from an African cohort.
    Nicoli F; Chachage M; Clowes P; Bauer A; Kowour D; Ensoli B; Cafaro A; Maboko L; Hoelscher M; Gavioli R; Saathoff E; Geldmacher C
    BMC Infect Dis; 2016 Jul; 16():344. PubMed ID: 27450538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.